The MHRA continues to speed up access to medicines for patients, increase efficiency of regulation and help to attract innovation and investment in the UK’s thriving £100 billion life sciences industry.
Follow this news feed:
Apr282026
MHRA delivers its targets to increase access to medicines and reinforce UK position as a global destination for life sciences